TCL Archive DeLap: Seven Years In industry Provided View Of Pressures On Drug Developers August 2, 1996
TCL Archive Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial January 27, 2012
TCL Archive Von Eschenbach Presents His “2015 Goal” As Logical Progression of Cancer Program (Interview) May 16, 2003
TCL Archive NCI Advisors Set SPORE Review Criteria, Approve Plan To Fund New Ovarian Grant June 26, 1998
TCL Archive Health Care Reform: Fundamental changes Ahead For Cancer Research And Care October 8, 1993
